{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:12:58Z","timestamp":1779264778645,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002080","name":"Everychild Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002080","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ophtha.2026.01.025","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:20:23Z","timestamp":1773058823000},"page":"764-774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children"],"prefix":"10.1016","volume":"133","author":[{"given":"Kara M.","family":"Cavuoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius T.","family":"Oatts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudha","family":"Nallasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Grace","family":"Prakalapakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan E.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupal H.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy L.","family":"Pineles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2026.01.025_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/pai.12197","article-title":"Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes","volume":"25","author":"Vichyanond","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.survophthal.2023.10.008","article-title":"Management of vernal keratoconjunctivitis: navigating a changing treatment landscape","volume":"69","author":"Ali","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jtos.2019.08.011","article-title":"Allergic eye disease in children and adolescents seeking eye care in India: electronic medical records driven big data analytics report II","volume":"17","author":"Das","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2026.01.025_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ophtha.2023.12.009","article-title":"Epidemiology of pediatric ocular surface inflammatory diseases in the United States using the Optum Labs Data Warehouse","volume":"131","author":"Fung","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.01.025_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1076\/0928-6586(200006)721-ZFT149","article-title":"A survey of vernal keratoconjunctivitis and other eosinophil-mediated external eye diseases amongst Palestinians","volume":"7","author":"O'Shea","year":"2000","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bjo.2007.117812","article-title":"Prevalence of vernal keratoconjunctivitis: a rare disease?","volume":"92","author":"Bremond-Gignac","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.eye.6700675","article-title":"Vernal keratoconjunctivitis","volume":"18","author":"Bonini","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ophtha.2026.01.025_bib8","article-title":"Vernal keratoconjunctivitis in adults: a narrative review of prevalence, pathogenesis, and management","volume":"4","author":"Di Zazzo","year":"2024","journal-title":"Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.ophtha.2026.01.025_bib9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1067\/mai.2000.111238","article-title":"Allergic and immunologic disorders of the eye. Part II: Ocular allergy","volume":"106","author":"Bielory","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1600-0420.2005.00622.x","article-title":"Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study","volume":"84","author":"Leonardi","year":"2006","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ophtha.2026.01.025_bib11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/all.12009","article-title":"Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface","volume":"67","author":"Leonardi","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.ophtha.2026.01.025_bib12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s40123-023-00665-5","article-title":"Novel insights in the management of vernal keratoconjunctivitis (VKC): European expert consensus using a modified nominal group technique","volume":"12","author":"Dahlmann-Noor","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ophtha.2026.01.025_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40123-013-0019-y","article-title":"Management of vernal keratoconjunctivitis","volume":"2","author":"Leonardi","year":"2013","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ophtha.2026.01.025_bib14","series-title":"Ophthalmic Medications and Pharmacology, 2nd ed","author":"Duvall","year":"2006"},{"key":"10.1016\/j.ophtha.2026.01.025_bib15","series-title":"The Oxford 2011 Levels of Evidence","year":"2014"},{"key":"10.1016\/j.ophtha.2026.01.025_bib17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2019.11.020","article-title":"Twelve-month results of cyclosporine a cationic emulsion in a randomized study in patients with pediatric vernal keratoconjunctivitis","volume":"212","author":"Bremond-Gignac","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00417-021-05356-0","article-title":"A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis","volume":"260","author":"Heikal","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ophtha.2018.12.027","article-title":"A randomized, controlled trial of cyclosporine a cationic emulsion in pediatric vernal keratoconjunctivitis: The VEKTIS study","volume":"126","author":"Leonardi","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.01.025_bib19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pai.12360","article-title":"Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: a randomized, comparative, double-blind, crossover study","volume":"26","author":"Pucci","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5935\/0004-2749.20170038","article-title":"Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial","volume":"80","author":"M\u00fcller","year":"2017","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/ICO.0000000000001200","article-title":"Comparative evaluation of tacrolimus versus interferon alpha-2b eye drops in the treatment of vernal keratoconjunctivitis: a randomized, double-masked study","volume":"36","author":"Zanjani","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2026.01.025_bib27","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/ICO.0000000000003368","article-title":"Efficacy of a cationic emulsion of cyclosporine in moderate vernal keratoconjunctivitis","volume":"43","author":"Caputo","year":"2024","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2026.01.025_bib22","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/ICO.0000000000002751","article-title":"Long-term safety and efficacy of tacrolimus 0.1% in severe pediatric vernal keratoconjunctivitis","volume":"40","author":"Caputo","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2026.01.025_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.18176\/jiaci.0282","article-title":"Tacrolimus as an effective and safe therapeutic alternative in vernal keratoconjunctivitis resistant to conventional treatment","volume":"28","author":"Gonz\u00e1lez-Medina","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib29","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.4103\/IJO.IJO_1393_23","article-title":"Reserve drug as first-line management: topical interferon alpha-2b for vernal keratoconjunctivitis","volume":"72","author":"Haral","year":"2024","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00417-019-04287-1","article-title":"Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis","volume":"257","author":"Liu","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2018.09.010","article-title":"Monotherapy of topical tacrolimus 0.03% in the treatment of vernal keratoconjunctivitis in the pediatric population","volume":"23","author":"Samyukta","year":"2019","journal-title":"J AAPOS"},{"key":"10.1016\/j.ophtha.2026.01.025_bib24","first-page":"1694","article-title":"Efficacy of single dose dermatological 0.1% tacrolimus ointment in the treatment of vernal keratoconjunctivitis","volume":"72","author":"Sharjeel","year":"2022","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.ophtha.2026.01.025_bib30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.4103\/ijp.IJP_174_20","article-title":"To evaluate the efficacy and safety of olopatadine 0.1% ophthalmic solution and bepotastine 1.5% ophthalmic solution in patients with vernal keratoconjunctivitis in a tertiary care hospital","volume":"52","author":"Sruthi","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ophtha.2026.01.025_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3126\/nepjoph.v12i1.24489","article-title":"Efficacy of topical cyclosporine 0.05% the treatment of vernal keratoconjunctivitis","volume":"12","author":"Subedi","year":"2020","journal-title":"Nepal J Ophthalmol"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026000540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026000540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:45:49Z","timestamp":1779263149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026000540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0161642026000540"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.01.025","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Ophthalmology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}